Early research (Phase 1)Study completedNCT01416324What this trial is testingFirst Time in Human Study Using GSK2330672Who this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT06378125What this trial is testingEvaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With PrediabetesWho this might be right forSafety IssuesPharmacokinetic University Hospital Schleswig-Holstein 60
Not applicableStudy completedNCT00841503What this trial is testingExploring Buckwheat's Glucose Lowering PotentialWho this might be right forType 2 Diabetes St. Boniface Hospital 24
Early research (Phase 1)Temporarily pausedNCT01114750What this trial is testingDetermine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)Who this might be right forDiabetes Mellitus Bows Pharmaceuticals AG 8
Not applicableStudy completedNCT01818674What this trial is testingMicroclinic Social Network Behavioral Health Trial in JordanWho this might be right forDiabetes Mellitus, Type 2ObesityHypertension+17 more Microclinic International 914
Early research (Phase 1)Study completedNCT05983289What this trial is testingSingle Escalating Dose Study Of HSK7653 In Healthy SubjectsWho this might be right forT2DM (Type 2 Diabetes Mellitus) Haisco Pharmaceutical Group Co., Ltd. 62
Early research (Phase 1)Study completedNCT01537497What this trial is testingEvaluate The Effects Of PF-05175157 In Healthy VolunteersWho this might be right forDiabetes Mellitus, Type 2 Pfizer 31
Early research (Phase 1)Study completedNCT05152277What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy SubjectsWho this might be right forType 2 Diabetes Fujian Shengdi Pharmaceutical Co., Ltd. 90
Early research (Phase 1)Study completedNCT05459285What this trial is testingA Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese SubjectsWho this might be right forType 2 Diabetes Sunshine Lake Pharma Co., Ltd. 68
Early research (Phase 1)Study completedNCT02373150What this trial is testingSafety, Tolerability and PK of Imeglimin in Japanese VolunteersWho this might be right forType 2 Diabetes Mellitus Poxel SA 48
Early research (Phase 1)Study completedNCT01515592What this trial is testingSafety and Tolerability of Liraglutide in Healthy Japanese Male VolunteersWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 24
Not applicableUnknownNCT04631913What this trial is testingMeta-analysis of Oats for Diabetes Prevention and ManagementWho this might be right forHealthyDiabetesMetabolic Syndrome+1 more University of Toronto 1
Early research (Phase 1)Study completedNCT01406262What this trial is testingAlbiglutide Thorough ECG Study in Healthy VolunteersWho this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 94
Early research (Phase 1)Study completedNCT01865331What this trial is testingSafety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese SubjectsWho this might be right forDiabetesHealthy Novo Nordisk A/S 32
Not applicableStudy completedNCT03419195What this trial is testingCardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of SexWho this might be right forType 2 Diabetes MellitusHealthyOverweight+1 more University of Colorado, Denver 124
Early research (Phase 1)Ended earlyNCT02744820What this trial is testingMultiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 DiabeticsWho this might be right forHealthyType 2 Diabetes Mellitus Genmedica Therapeutics S.L. 34
Not applicableStudy completedNCT02343146What this trial is testingHealthy Eating, Physical Activity, and Glycemic Control in Young Children With T1DWho this might be right forDiabetes Mellitus, Type 1 Randi Streisand 46
Early research (Phase 1)Study completedNCT01240980What this trial is testingSafety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)Who this might be right forDiabetes Bristol-Myers Squibb 104
Early research (Phase 1)Study completedNCT06548815What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4Who this might be right forDiabetes Gan and Lee Pharmaceuticals, USA 43
Not applicableStudy completedNCT02134860What this trial is testingBed Rest, Alternate Daily Fasting and Incretin EffectWho this might be right forMetabolic SyndromeType 2 DiabetesCritical Illness Rigshospitalet, Denmark 20